IRIS Institutional Research Information System - OPENBS Open Archive UniBS

DE PETRO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.507
EU - Europa 4.990
AS - Asia 1.772
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 18
OC - Oceania 14
SA - Sud America 7
Totale 12.331
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.461
PL - Polonia 1.455
CN - Cina 1.155
DE - Germania 973
UA - Ucraina 923
IT - Italia 509
FI - Finlandia 243
FR - Francia 238
HK - Hong Kong 227
GB - Regno Unito 226
IN - India 185
IE - Irlanda 152
RU - Federazione Russa 101
SE - Svezia 90
VN - Vietnam 72
BE - Belgio 47
SG - Singapore 47
CA - Canada 43
TR - Turchia 35
EU - Europa 21
AU - Australia 12
IR - Iran 11
MU - Mauritius 7
SD - Sudan 7
TH - Thailandia 7
KR - Corea 6
NL - Olanda 6
RO - Romania 5
BG - Bulgaria 3
BR - Brasile 3
ID - Indonesia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
ES - Italia 2
GE - Georgia 2
IL - Israele 2
MA - Marocco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
IM - Isola di Man 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
TM - Turkmenistan 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 12.331
Salva come PNG Salva come JPEG
Città #
Warsaw 1.455
Jacksonville 671
Fairfield 601
Woodbridge 469
Chandler 459
Ann Arbor 388
Ashburn 355
Houston 308
Wilmington 290
Princeton 286
Nanjing 264
Cambridge 261
Seattle 228
Hong Kong 223
Beijing 213
New York 162
Dearborn 151
Dublin 151
Brescia 149
Helsinki 127
Nanchang 91
Shenyang 71
Dong Ket 70
Jinan 68
Hebei 67
Des Moines 62
Changsha 52
Jiaxing 49
Tianjin 47
Brussels 45
Lancaster 42
Kunming 39
Milan 38
Pune 31
Shanghai 30
San Diego 29
Kocaeli 25
Verona 25
Hangzhou 22
Toronto 22
San Francisco 21
Los Angeles 20
Zhengzhou 20
Ningbo 18
North York 18
Nürnberg 17
London 13
Guangzhou 12
Haikou 12
Lanzhou 12
Redwood City 12
Boardman 11
Norwalk 11
Taizhou 11
Bologna 10
Fuzhou 10
Hefei 9
Orange 9
Bari 8
Lappeenranta 8
Phoenix 8
Sundbyberg 8
Magnago 7
Melbourne 7
Taiyuan 7
Napoli 6
San Mateo 6
Singapore 6
Augusta 5
Borås 5
Brooklyn 5
Castelnuovo Bozzente 5
Naples 5
Pontevico 5
Rockville 5
Washington 5
Berlin 4
Changchun 4
Chicago 4
Licata 4
Parma 4
San Gregorio Magno 4
Daejeon 3
Hat Yai 3
Indiana 3
Kilburn 3
Melfi 3
Palermo 3
Paris 3
Philadelphia 3
Prescot 3
Rome 3
Rosà 3
Sabz 3
San Paolo 3
Treviglio 3
Trieste 3
Véry 3
Almaty 2
Altamura 2
Totale 8.569
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 311
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 276
Environment and bladder cancer: molecular analysis by interaction networks 271
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 213
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 197
Functional Role of microRNA-23b-3p in Cancer Biology 184
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 181
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 180
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers 175
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 174
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 156
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 154
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 145
Preparazione di colture primarie di fibroblasti di embrione di pollo . 144
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 144
Biological Function of MicroRNA193a-3p in Health and Disease 135
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 132
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 130
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 130
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 130
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 130
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 129
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 126
microRNAs and human hepatocellular carcinoma 122
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 121
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma 120
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 118
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 113
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 109
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 108
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 108
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 107
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 107
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 107
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease 103
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 101
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 100
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 100
Interaction of tissue type plasminogen activator with fibronectin and fibronectin fragments 97
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 97
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 96
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 96
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 95
Transformation-enhancing activity of gelatin binding fragments of fibronectin 95
Transformation enhancing activity in plasma of tumor patients: relationship with fibronectin fragments 95
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 95
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 95
Transformation enhancing activity present in the plasma of cancer patients binds to gelatin. 94
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 94
A rapid and highly sensitive solid phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody 94
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 93
Inhibition of Rous sarcoma virus-induced transformation by proteins involved in blood coagulation 93
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 92
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts 90
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. 90
Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them 89
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 87
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 85
Role of fibronectin degradation products on cellular transformation. 84
Studi per lo sviluppo di terapie innovative molecolari per l’epatocarcinoma cellulare: microRNA e sorafenib. 82
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 81
Tissue-type plasminogen activator but not urokinase exerts transformation enhancing activity 80
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 80
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 78
Phosphorylation of human plasminogen activators and plasminogen. 75
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 75
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 74
Urokinase and c-met are target of miR-23b in human cells. 72
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 72
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 72
u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor in RNA is down regulated in human hepatocellular carcinoma 72
RT-PCR detection of EDA+ fibronectin mRNA isoforms as hepatocarcinoma markers. 71
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 69
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 69
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 67
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 66
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 66
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 66
Utilization of Rous sarcoma virus for the detection of transformation enhancing and inhibiting factors in human plasma. 65
Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. 65
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 64
Transformation enhancing factors and fibronectin degradation products as possible tumor markers. 64
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 63
Transformation enhancing factors in vitro and in vivo. Potential as cancer markers 62
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 62
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 62
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 62
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 62
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 61
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 61
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 61
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 61
Fibronectin and its proteolitic fragments : potential as cancer markers 60
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 60
RNA interference for urokinase gene in human hepatocellular carcinoma 60
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 60
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 59
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 59
Conditional interactions of fibronectin: C-reactive protein, sulfated proteoglycans, and malignant transformation. 59
La trascrizione in Molecole, cellule e Organismi 59
Totale 10.275
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019398 0 0 0 0 0 0 0 0 0 0 213 185
2019/20203.628 505 153 173 326 188 423 381 377 231 473 204 194
2020/20212.086 57 252 51 252 72 246 95 242 324 203 180 112
2021/20221.171 62 215 49 73 10 40 49 66 65 127 129 286
2022/20231.232 185 62 35 122 116 293 13 104 182 10 48 62
2023/20241.086 95 31 135 75 63 267 83 45 233 51 8 0
Totale 12.648